Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Dyne Therapeutics Inc (NASDAQ: DYN) closed the day trading at $28.62 down -0.56% from the previous closing price of $28.78. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 0.85 million shares were traded. DYN stock price reached its highest trading level at $29.005 during the session, while it also had its lowest trading level at $28.25.
Ratios:
For a better understanding of DYN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.63 and its Current Ratio is at 26.63. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on October 24, 2024, Downgraded its rating to Neutral and sets its target price to $35 from $43 previously.
On May 21, 2024, Chardan Capital Markets reiterated its Buy rating and also lowered its target price recommendation from $31 to $42.
On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.Morgan Stanley initiated its Overweight rating on April 30, 2024, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 18 ’24 when Kersten Dirk sold 13,414 shares for $35.16 per share. The transaction valued at 471,636 led to the insider holds 73,225 shares of the business.
Kersten Dirk sold 121 shares of DYN for $4,242 on Oct 21 ’24. The Director now owns 73,104 shares after completing the transaction at $35.06 per share. On Oct 16 ’24, another insider, Kersten Dirk, who serves as the Director of the company, sold 23,671 shares for $35.35 each. As a result, the insider received 836,770 and left with 99,652 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 2873476608 and an Enterprise Value of 2120349824.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $7.93. The 50-Day Moving Average of the stock is -15.78%, while the 200-Day Moving Average is calculated to be -10.02%.
Shares Statistics:
Over the past 3-months, DYN traded about 1.25M shares per day on average, while over the past 10 days, DYN traded about 809710 shares per day. A total of 100.40M shares are outstanding, with a floating share count of 75.28M. Insiders hold about 25.02% of the company’s shares, while institutions hold 86.55% stake in the company. Shares short for DYN as of 1728950400 were 9110273 with a Short Ratio of 7.31, compared to 1726185600 on 7660014. Therefore, it implies a Short% of Shares Outstanding of 9110273 and a Short% of Float of 10.8.
Earnings Estimates
As of right now, 10.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.62 and low estimates of -$0.85.
Analysts are recommending an EPS of between -$2.75 and -$3.29 for the fiscal current year, implying an average EPS of -$3.0. EPS for the following year is -$3.16, with 10.0 analysts recommending between -$2.56 and -$3.49.
